Literature DB >> 11511331

Optimizing antibiotic therapy in the intensive care unit setting.

M H Kollef1.   

Abstract

Antibiotics are one of the most common therapies administered in the intensive care unit setting. In addition to treating infections, antibiotic use contributes to the emergence of resistance among pathogenic microorganisms. Therefore, avoiding unnecessary antibiotic use and optimizing the administration of antimicrobial agents will help to improve patient outcomes while minimizing further pressures for resistance. This review will present several strategies aimed at achieving optimal use of antimicrobial agents. It is important to note that each intensive care unit should have a program in place which monitors antibiotic utilization and its effectiveness. Only in this way can the impact of interventions aimed at improving antibiotic use (e.g. antibiotic rotation, de-escalation therapy) be evaluated at the local level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511331      PMCID: PMC137278          DOI: 10.1186/cc1022

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  51 in total

1.  Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system.

Authors:  L Leibovici; V Gitelman; Y Yehezkelli; O Poznanski; G Milo; M Paul; P Ein-Dor
Journal:  J Intern Med       Date:  1997-11       Impact factor: 8.989

Review 2.  The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital.

Authors:  H Giamarellou; A Antoniadou
Journal:  Ciba Found Symp       Date:  1997

Review 3.  Treatment and prevention of nosocomial pneumonia.

Authors:  E Bergogne-Bérézin
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

4.  Improving empiric antibiotic selection using computer decision support.

Authors:  R S Evans; D C Classen; S L Pestotnik; H P Lundsgaarde; J P Burke
Journal:  Arch Intern Med       Date:  1994-04-25

5.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

Authors:  M H Kollef; S Ward
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

6.  The role of understaffing in central venous catheter-associated bloodstream infections.

Authors:  S K Fridkin; S M Pear; T H Williamson; J N Galgiani; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1996-03       Impact factor: 3.254

7.  A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.

Authors:  T C Bailey; D J Ritchie; S T McMullin; M Kahn; R M Reichley; E Casabar; W Shannon; W C Dunagan
Journal:  Pharmacotherapy       Date:  1997 Mar-Apr       Impact factor: 4.705

8.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.

Authors:  Y Siegman-Igra; R Ravona; H Primerman; M Giladi
Journal:  Int J Infect Dis       Date:  1998 Apr-Jun       Impact factor: 3.623

10.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

View more
  20 in total

1.  Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Authors:  Vanthida Huang; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.

Authors:  Shiva Sarraf-Yazdi; Michelle Sharpe; Kyla M Bennett; Tim L Dotson; Deverick J Anderson; Steven N Vaslef
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

3.  Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.

Authors:  Liesbet De Bus; Wouter Denys; Julie Catteeuw; Bram Gadeyne; Karel Vermeulen; Jerina Boelens; Geert Claeys; Jan J De Waele; Johan Decruyenaere; Pieter O Depuydt
Journal:  Intensive Care Med       Date:  2016-03-30       Impact factor: 17.440

4.  A focus on intra-abdominal infections.

Authors:  Massimo Sartelli
Journal:  World J Emerg Surg       Date:  2010-03-19       Impact factor: 5.469

Review 5.  Advances in sepsis therapy.

Authors:  Thomas Glück; Steven M Opal
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient.

Authors:  Yogandree Ramsamy; Timothy C Hardcastle; David J J Muckart
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

7.  [Not Available].

Authors:  R Le Floch; E Naux; J F Arnould
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

8.  Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?

Authors:  Andrey V Kozlov; Soheyl Bahrami; Enrico Calzia; Peter Dungel; Lars Gille; Andrey V Kuznetsov; Jakob Troppmair
Journal:  Ann Intensive Care       Date:  2011-09-26       Impact factor: 6.925

9.  Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.

Authors:  Andrea Endimiani; Gioconda Brigante; Alessia A Bettaccini; Francesco Luzzaro; Paolo Grossi; Antonio Q Toniolo
Journal:  BMC Infect Dis       Date:  2005-11-24       Impact factor: 3.090

10.  ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.

Authors:  Kiran Shekar; Jason A Roberts; Susan Welch; Hergen Buscher; Sam Rudham; Fay Burrows; Sussan Ghassabian; Steven C Wallis; Bianca Levkovich; Vin Pellegrino; Shay McGuinness; Rachael Parke; Eileen Gilder; Adrian G Barnett; James Walsham; Daniel V Mullany; Yoke L Fung; Maree T Smith; John F Fraser
Journal:  BMC Anesthesiol       Date:  2012-11-28       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.